Showing results (111-120 of 339) with videos related to
Sort By:
Pageof 34
Stem Cells Translational Medicine|July 3, 2015
Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore AntibioticsMaximilian Boesch, Alain G Zeimet, Holger Rumpold, et al.Biochemical and Biophysical Research Communications|July 31, 2007
Knockdown of PgP resensitizes leukemic cells to proteasome inhibitorsHolger Rumpold, Christina Salvador, Anna Maria Wolf, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|July 3, 2019
Fibroblasts in cancer: Defining target structures for therapeutic interventionMaximilian Boesch, Florent Baty, Holger Rumpold, et al.Leukemia & Lymphoma|August 21, 2024
Reduced prognostic value of beta-2-microglobulin for time to first treatment in CLL patients with compromised kidney functionJan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, et al.Haematologica|September 8, 2006
The effect of zoledronic acid on the function and differentiation of myeloid cellsAnna Maria Wolf, Holger Rumpold, Herbert Tilg, et al.The International Journal of Clinical and Experimental Hypnosis|February 20, 2016
Effectiveness of Self-Hypnosis on the Relief of Experimental Dental Pain: A Randomized TrialThomas Gerhard Wolf, Dominik Wolf, Dagna Below, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Bosutinib: A Potent Second-Generation Tyrosine Kinase InhibitorSusanne Isfort, Martina Crysandt, Deniz Gezer, et al.Therapeutic Advances in Hematology|August 4, 2022
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case reportJan-Paul Bohn, Anna Fiala, Sebastian Bachmann, et al.Journal of Leukocyte Biology|July 22, 2025
Decreased HLA-DR+CD3+ T cells three months after allogeneic stem cell transplantation predict severe chronic GvHD and transplant-related mortalityStefan Koeck, Gabriele Hetzenauer, Ines Peschel-Schaar, et al.Experimental Hematology|June 21, 2005
RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell linesHolger Rumpold, Anna M Wolf, Kurt Gruenewald, et al.Pageof 34